The MITF/Mir-579-3p Regulatory Axis Dictates BRAF-Mutated Melanoma Cell Fate in Response to MAPK Inhibitors

Researchers showed that miR-579-3p was specifically deregulated in BRAF-mutant melanomas and that its expression levels mirrored those of microphthalmia-associated transcription factor (MITF).